参考文献:1. Centers for Disease Control and Prevention. Heart Disease Facts. Available at: http://www.cdc.gov/heartdisease/facts.htm. Accessed June 9, 2014. 2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988鈥?008. JAMA. 2010;303:2043鈥?0. CrossRef 3. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J. 2005;149:785鈥?4. CrossRef 4. World Health Organization. Adherence to long-term therapies: evidence for action. Noncommunicable Diseases and Mental Health Adherence to long-term therapies project. http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf. Accessed June 9, 2014. 5. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203鈥?2. CrossRef 6. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772鈥?. CrossRef 7. Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271鈥?. CrossRef 8. Becker M, Maiman L. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10鈥?4. CrossRef 9. Kumbhani DJ, Fonarow GC, Cannon CP, Get With the Guidelines Steering Committee and Investigators, et al. Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med. 2013;126(1):74.e1-9. CrossRef 10. Sanf茅lix-Gimeno G, Peir贸 S, Ferreros I, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm. 2013;19(3):247鈥?7. 11. Kirchmayer U, Agabiti N, Belleudi V, et al. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy. J Clin Pharm Ther. 2012;37(1):37鈥?4. CrossRef 12. Rodriguez F, Cannon CP, Steg PG, REACH Registry Investigators, et al. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry. Clin Cardiol. 2013;36(12):721鈥?. CrossRef 13. Shah BR, Adams M, Peterson ED, et al. Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management. Circ Cardiovasc Qual Outcomes. 2011;4(2):235鈥?2. CrossRef 14. Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, et al. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group. Value Health. 2013;16(5):891鈥?00. CrossRef 15. Crowley MJ, Grubber JM, Olsen MK, Bosworth HB. Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med. 2013;28:99鈥?06. CrossRef 16. Parker RM, Baker DW, Williams MV, et al. The test of functional health literacy in adults: a new instrument for measuring patients鈥?literacy skills. J Gen Intern Med. 1995;10:537鈥?1. CrossRef 17. Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70:338鈥?7. CrossRef 18. Powers BJ, Danus S, Grubber JM, et al. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J. 2011;161(4):673鈥?0. CrossRef 19. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284鈥?2. CrossRef 20. Zullig LL, Shaw RJ, Crowley MJ, et al. Association between perceived life chaos and medication adherence in a postmyocardial infarction population. Circ Cardiovasc Qual Outcomes. 2013;6(6):619鈥?5. CrossRef 21. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67鈥?4. CrossRef 22. Lowry KP, Dudley TK, Oddone EZ, et al. Intentional and unintentional non-adherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198鈥?03. CrossRef 23. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication non-adherence. J Clin Epidemiol. 2011;64:250鈥?. CrossRef 24. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004;13:11鈥?. CrossRef 25. Feinstein A. Compliance bias and the interpretation of therapeutic trials. In: Haynes RB, Taylor D, Sackeets DL, eds. Compliance in Health Care. Baltimore: The Johns Hopkins University Press; 1979:309鈥?2. 26. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol. 2006;59:650鈥?. CrossRef 27. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication non-adherence: response to authors. J Clin Epidemiol. 2011;64:255鈥?. CrossRef